Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma…
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent…
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Finance
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Authors
Posts by Matt Wade
Matt Wade
403 POSTS
0 COMMENTS
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
How the Oil Spike Could Spur a Stampede into Alternative Energy...
Matt Wade
-
March 23, 2022
0
BridgeBio Pharma Inc (NASDAQ: BBIO) Issues an Update to Its Shareholders...
Matt Wade
-
March 21, 2022
0
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Recently Plans to Close Its...
Matt Wade
-
March 21, 2022
0
Freeline Therapeutics Holdings (NASDAQ: FRLN) Dose its First Patient in B-LIEVE...
Matt Wade
-
March 18, 2022
0
Denali Therapeutics Inc (NASDAQ: DNLI) Issues an Update on Clinic Trials...
Matt Wade
-
March 17, 2022
0
1
...
14
15
16
...
81
Page 15 of 81
Recent Post
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows...
Kate Hudson
-
May 8, 2024
0
Actinium Pharmaceuticals (ATNM) shares saw slight volatility on Tuesday, closing at $8.81 (-0.34%). However, recent announcements concerning the company's Iomab-ACT project could...
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma...
May 7, 2024
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent...
May 2, 2024
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
May 1, 2024
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...
May 1, 2024